Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 34.84% | 11.65% | -17.99% | -22.84% | -27.89% |
| Total Depreciation and Amortization | -2.86% | -0.66% | 0.15% | -0.76% | -0.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 269.80% | 142.79% | -17.55% | -44.74% | -56.88% |
| Change in Net Operating Assets | -4,253.71% | -4,253.71% | -4,253.71% | -221.47% | 107.30% |
| Cash from Operations | 31.07% | -18.88% | -89.72% | -62.64% | -37.74% |
| Capital Expenditure | 63.86% | 72.33% | 78.14% | 39.78% | -46.90% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 63.86% | 72.33% | 78.14% | 39.78% | -46.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.14% | -6.23% | -17.09% | -13.58% | -9.89% |
| Issuance of Common Stock | 113.39% | 270.93% | 2,015.79% | 1,421.06% | 889.65% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -151.26% | -385.76% | -- | -7,414.85% | -2,146.53% |
| Cash from Financing | 114.75% | 273.02% | 2,028.10% | 1,434.84% | 902.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 224.30% | 223.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 458.34% | 211.89% | 111.94% | 86.89% | 61.46% |